FdaApplication
ANDA 209721
Identifiers
- fda_app_no: ANDA209721
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS CO GMBH |
| application_type | ANDA |
| approval_date | 2018-08-22 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 100MG;150MG | TABLET;ORAL |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 133MG;200MG | TABLET;ORAL |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 200MG;300MG | TABLET;ORAL |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 167MG;250MG | TABLET;ORAL |
4 products